Steadtrust’s ImmuCell ICCC Stock Holding History

Steadtrust’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Sell	45,370 -9,000	-17%	-$79.5K	0.23%	93
2026 Q1	$344K	Sell	54,370 -2,400	-4%	-$15.4K	0.2%	97
2025 Q4	$349K	Buy	56,770 +25,070	+79%	+$148K	0.21%	96
2025 Q3	$198K	Buy	+31,700	New	+$200K	0.13%	114

Other funds holding ICCC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Steadtrust's ICCC Position: Q2 2026 in Review

Steadtrust reduced its ImmuCell (ICCC) stake by 17% in Q2 2026, selling an estimated $79.5K and leaving 45,370 shares worth $456K. The position accounts for 0.23% of the portfolio, ranked #93.

Steadtrust first reported a position in ICCC in Q3 2025 and has held it in 4 quarters since. 30 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Steadtrust held 45,370 shares of ImmuCell worth $456K as of Q2 2026.
Steadtrust sold 9,000 ImmuCell shares in Q2 2026, an estimated $79.5K.
ImmuCell made up 0.23% of Steadtrust's portfolio in Q2 2026, its #93 holding.
Steadtrust first reported a position in ImmuCell in Q3 2025 and has held it in 4 quarters since.
30 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.